Berger Dietmar bought GILD
March 10, 2025 · Form 4 insider transaction
Berger Dietmar bought 37,710 shares of Gilead Sciences, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
37,710
Price
$0.00
Total value
N/A
InsiderBerger Dietmar
Role—
CompanyGilead Sciences, Inc. (GILD)
SecurityNon-qualified Stock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateMarch 10, 2025
Filing dateMarch 12, 2025
Shares owned after37,710
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The options have a four-year vesting schedule. 25% vest on the first anniversary of the date of grant. The balance will vest 6.25% quarterly thereafter until fully vested.